Wednesday, August 09, 2006
SYNTHETIC BLOOD TRIAL CONTINUES 8/9/06
Two Additional Traumatic Brain Injury Patients Treated in Synthetic Blood Trial
COSTA MESA, Calif.--(BUSINESS WIRE)--Aug 9, 2006 -
Synthetic Blood International, Inc. (OTCBB:SYBD) today announced treatment of the seventh and eighth patients in its Phase IIa proof-of-concept Oxycyte(TM) study in traumatic brain injury. Consistent with the results in previous patients treated in this trial, Oxycyte administration in the two most recently treated patients significantly increased brain oxygen tension over baseline...
..."Currently, there is no direct therapy for the 1.4 million Americans each year who sustain traumatic brain injury," said Robert Nicora, Synthetic Blood President and CEO. "The results of this trial are exciting because previous studies have shown that increasing brain oxygen levels in patients with severe brain injury is associated with a better clinical outcome relative to cognitive and motor function. We believe the positive study data to date provides a significant basis for initiating a Phase IIb Oxycyte trial in a larger traumatic brain injury patient population."...
...Oxycyte is administered to patients with severe traumatic brain injury and a Glasgow Coma Scale score of 3-9. The primary purpose of this study is to demonstrate Oxycyte's ability to increase brain oxygen tension and favorably affect other brain chemistries that impact clinical outcome in patients suffering severe head injury. Additionally, the study will further assess the safety of Oxycyte when given by intravenous infusion...
[The complete article is available at:]
http://www.medadnews.com/News/Index.cfm?articleid=364360#
sapphoq applauds research in the field of brain injury which may result in demonstrable and measurable improved outcomes for future patients with brain injury. To be afraid of carefully designed technological clinical trials is to deny many human beings hope. Medical progress depends upon data which has an ability to be tested and reproduced. Although it may be popular among pagans and cowan both to deny careful evidence that some of our pet treatments and ideas about the way things work do not hold up under rigorous investigation, it remains vitally important that researchers continue to conduct such investigations. Fundamentalism of any kind along with its' twin sentamentality are the natural enemies of logical thought.
~sapphoq
¶ 9:58 PM
COSTA MESA, Calif.--(BUSINESS WIRE)--Aug 9, 2006 -
Synthetic Blood International, Inc. (OTCBB:SYBD) today announced treatment of the seventh and eighth patients in its Phase IIa proof-of-concept Oxycyte(TM) study in traumatic brain injury. Consistent with the results in previous patients treated in this trial, Oxycyte administration in the two most recently treated patients significantly increased brain oxygen tension over baseline...
..."Currently, there is no direct therapy for the 1.4 million Americans each year who sustain traumatic brain injury," said Robert Nicora, Synthetic Blood President and CEO. "The results of this trial are exciting because previous studies have shown that increasing brain oxygen levels in patients with severe brain injury is associated with a better clinical outcome relative to cognitive and motor function. We believe the positive study data to date provides a significant basis for initiating a Phase IIb Oxycyte trial in a larger traumatic brain injury patient population."...
...Oxycyte is administered to patients with severe traumatic brain injury and a Glasgow Coma Scale score of 3-9. The primary purpose of this study is to demonstrate Oxycyte's ability to increase brain oxygen tension and favorably affect other brain chemistries that impact clinical outcome in patients suffering severe head injury. Additionally, the study will further assess the safety of Oxycyte when given by intravenous infusion...
[The complete article is available at:]
http://www.medadnews.com/News/Index.cfm?articleid=364360#
sapphoq applauds research in the field of brain injury which may result in demonstrable and measurable improved outcomes for future patients with brain injury. To be afraid of carefully designed technological clinical trials is to deny many human beings hope. Medical progress depends upon data which has an ability to be tested and reproduced. Although it may be popular among pagans and cowan both to deny careful evidence that some of our pet treatments and ideas about the way things work do not hold up under rigorous investigation, it remains vitally important that researchers continue to conduct such investigations. Fundamentalism of any kind along with its' twin sentamentality are the natural enemies of logical thought.
~sapphoq
¶ 9:58 PM
